# Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

> clinical trial · VERIFIED · 2026-07-29

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Synovial Sarcoma

- Company: M.D. Anderson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06083883

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.